G J Vosika - JoVE Visualize

Showing results (11-20 of 18) with videos related to

Pageof 2

Sort By:

You have reached the last page of results.This site can display upto 18 results.

Molecular Biotherapy|March 1, 1990

Immunologic and toxicologic study of disaccharide tripeptide glycerol dipalmitoyl: a new lipophilic immunomodulatorG J Vosika, D A Cornelius, J A Bennek, et al.

In Vitro|March 1, 1978

Studies on the transformation of rat embryo cells of low passage by carcinogenic fluorenylhydroxamic acids and their acetate estersH Kurzepa, H R Gutmann, D Malejka-Giganti, et al.

Journal of Immunotherapy : Official Journal of the Society for Biological Therapy|August 1, 1991

Phase I trial of ImmTher, a new liposome-incorporated lipophilic disaccharide tripeptideG J Vosika, D A Cornelius, C W Gilbert, et al.

Medical and Pediatric Oncology|January 1, 1978

CCNU, vinblastine, and delalutin therapy in renal cell carcinomaG J Vosika, M J Ryan, I A Fortuny, et al.

Cancer Treatment Reports|September 1, 1981

Phase II study of diglycoaldehyde in malignant melanomas and soft tissue sarcomasG J Vosika, K Briscoe, R W Carey, et al.

Anticancer Research|January 1, 1981

Clinical trials with diglycoaldehyde (NSC-118994): review and reasons for withdrawal from clinical trialD F Chiuten, G J Vosika, M T Shaw, et al.

Proceedings of the National Academy of Sciences of the United States of America|July 1, 1975

Oncornavirus-like particles from cultured bone marrow cells preceding leukemia and malignant histiocytosisG J Vosika, W Krivit, J M Gerrard, et al.

Cancer Treatment Reports|August 1, 1980

Chemotherapy for small cell bronchogenic carcinoma: CCNU and doxorubicin compared to CCNU, doxorubicin, vincristine, and procarbazineN J Vogelzang, R C Trowbridge, D H Frenning, et al.

Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:

Pageof 2

You have reached the last page of results.This site can display upto 18 results.

Molecular Biotherapy|March 1, 1990

Immunologic and toxicologic study of disaccharide tripeptide glycerol dipalmitoyl: a new lipophilic immunomodulatorG J Vosika, D A Cornelius, J A Bennek, et al.

In Vitro|March 1, 1978

Studies on the transformation of rat embryo cells of low passage by carcinogenic fluorenylhydroxamic acids and their acetate estersH Kurzepa, H R Gutmann, D Malejka-Giganti, et al.

Journal of Immunotherapy : Official Journal of the Society for Biological Therapy|August 1, 1991

Phase I trial of ImmTher, a new liposome-incorporated lipophilic disaccharide tripeptideG J Vosika, D A Cornelius, C W Gilbert, et al.

Medical and Pediatric Oncology|January 1, 1978

CCNU, vinblastine, and delalutin therapy in renal cell carcinomaG J Vosika, M J Ryan, I A Fortuny, et al.

Cancer Treatment Reports|September 1, 1981

Phase II study of diglycoaldehyde in malignant melanomas and soft tissue sarcomasG J Vosika, K Briscoe, R W Carey, et al.

Anticancer Research|January 1, 1981

Clinical trials with diglycoaldehyde (NSC-118994): review and reasons for withdrawal from clinical trialD F Chiuten, G J Vosika, M T Shaw, et al.

Proceedings of the National Academy of Sciences of the United States of America|July 1, 1975

Oncornavirus-like particles from cultured bone marrow cells preceding leukemia and malignant histiocytosisG J Vosika, W Krivit, J M Gerrard, et al.

Cancer Treatment Reports|August 1, 1980

Chemotherapy for small cell bronchogenic carcinoma: CCNU and doxorubicin compared to CCNU, doxorubicin, vincristine, and procarbazineN J Vogelzang, R C Trowbridge, D H Frenning, et al.

Pageof 2